The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Duke Medical Center, Thomas Jefferson University, Sidney Kimmel Cancer Center, Duke University, University of Southern California, Université Paris-Sud, Institut Gustave Roussy, University of Toronto, Princess Margaret Cancer Centre, Yale University, Memorial Sloan Kettering Cancer Center, University of California, San Francisco
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1785160942